O. S. Voroniak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
O. S. Voroniak has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- R. O. Zograbian
State Institution “O.O. Shalimov National Institute of Surgery and Transplantology” of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
4 shared publications R.O. Zograbyan
Национальный институт хирургии и трансплантологии имени А.А. Шалимова, г. Киев, Украина
2 shared publicationsA.V. Kubashko
State Institution “O.O. Shalimov National Institute of Surgery and Transplantology”, Kyiv, Ukraine
1 shared publicationD. V. Kostiuk
Shalimov National Institute of Surgery and Transplantology, Kyiv
1 shared publication- Mykyta Nechaiev
Державне некомерційне підприємство «Національна спеціалізована дитяча лікарня «Охматдит» Міністерства охорони здоровʼя України», Київ, Україна; Національний медичний університет імені О.О. Богомольця Міністерства охорони здоровʼя України, Київ, Україна
1 shared publication - Ruslan V. Salyutin
Shalimov National Scientific Centre of Surgery and Transplantation of the National Academy of Medical Sciences of Ukraine, Kyiv
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (2) , 198-212
Late acute kidney allograft rejection: clinical, laboratory and functional imaging predictors
Background. The development of late acute rejection (LAR) remains one of the leading factors of renal allograft dysfunction in the long-term period after surgery. The specificity of this complication, in contrast to early crises, lies in the latent unfolding of the clinical picture. Since the manifestation of LAR often occurs without sharp fluctuations in traditional markers of nitrogen excretory function (in particular, the level of serum creatinine and urea), early verification of the pathological process constitutes a significant diagnostic problem for clinicians.Purpose – to comprehensively investigate the spectrum of clinical, laboratory, and instrumental markers of late acute renal allograft rejection, with determination of the leading diagnostic and prognostic role of quantitative parameters of dynamic radionuclide imaging.Materials and methods. Clinical data, serum creatinine concentration, estimated glomerular filtration rate (eGFR), CRP level, ESR, dynamic renoscintigraphy parameters, and the results of histological examination of kidney biopsies were analyzed in 22 recipients with RT dysfunction that occurred 6 months after transplantation. The comparison group consisted of 28 recipients with satisfactory graft function 6 months after kidney transplantation.Results. In the study group, lower eGFR values (32 vs. 51 ml/min/1.73 m2; p < 0.001) and higher levels of inflammatory markers were detected: ESR (22 vs. 16 mm/h; p = 0.021) and C-reactive protein (8.9 vs. 4.8 mg/l; p = 0.048). According to the data of dynamic renoscintigraphy, a sequential decrease in graft perfusion and function was observed: perfusion index (PI) from 1.02 to 0.82 and 0.65, functional index (FI) from 0.99 to 0.75 and 0.69 (p < 0.001). An inverse relationship was established between the degree of glomerular damage and eGFR. According to the results of multivariate analysis, the independent factors associated with LAR were a decrease in GFR ( = –0.2845; p < 0.0001), deterioration of PI ( = 4.213; p = 0.0379), a decrease in FI ( = 1.092; p = 0.0247), and an increase in ESR ( = 0.3187; p = 0.0096). The relationship with the creatinine level was less pronounced ( = 0.1294; p = 0.035).Conclusions. According to the obtained data, LAR is accompanied by early changes in RT perfusion and function according to dynamic renoscintigraphy data, which may precede changes (increase) in serum creatinine concentration. The use of functional imaging together with standard monitoring of the graft status increases the efficiency of pathology detection and promotes early clinical response. The combination of renoscintigraphy parameters, GFR, CRP, and ESR can be one of the non-invasive markers for diagnosing RT pathology, which improves the risk assessment of late graft rejection.
- 30 June 2026
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (2) , 198-212
Open AccessLate acute kidney allograft rejection: clinical, laboratory and functional imaging predictors
Background. The development of late acute rejection (LAR) remains one of the leading factors of renal allograft dysfunction in the long-term period after surgery. The specificity of this complication, in contrast to early crises, lies in the latent unfolding of the clinical picture. Since the manifestation of LAR often occurs without sharp fluctuations in traditional markers of nitrogen excretory function (in particular, the level of serum creatinine and urea), early verification of the pathological process constitutes a significant diagnostic problem for clinicians.Purpose – to comprehensively investigate the spectrum of clinical, laboratory, and instrumental markers of late acute renal allograft rejection, with determination of the leading diagnostic and prognostic role of quantitative parameters of dynamic radionuclide imaging.Materials and methods. Clinical data, serum creatinine concentration, estimated glomerular filtration rate (eGFR), CRP level, ESR, dynamic renoscintigraphy parameters, and the results of histological examination of kidney biopsies were analyzed in 22 recipients with RT dysfunction that occurred 6 months after transplantation. The comparison group consisted of 28 recipients with satisfactory graft function 6 months after kidney transplantation.Results. In the study group, lower eGFR values (32 vs. 51 ml/min/1.73 m2; p < 0.001) and higher levels of inflammatory markers were detected: ESR (22 vs. 16 mm/h; p = 0.021) and C-reactive protein (8.9 vs. 4.8 mg/l; p = 0.048). According to the data of dynamic renoscintigraphy, a sequential decrease in graft perfusion and function was observed: perfusion index (PI) from 1.02 to 0.82 and 0.65, functional index (FI) from 0.99 to 0.75 and 0.69 (p < 0.001). An inverse relationship was established between the degree of glomerular damage and eGFR. According to the results of multivariate analysis, the independent factors associated with LAR were a decrease in GFR ( = –0.2845; p < 0.0001), deterioration of PI ( = 4.213; p = 0.0379), a decrease in FI ( = 1.092; p = 0.0247), and an increase in ESR ( = 0.3187; p = 0.0096). The relationship with the creatinine level was less pronounced ( = 0.1294; p = 0.035).Conclusions. According to the obtained data, LAR is accompanied by early changes in RT perfusion and function according to dynamic renoscintigraphy data, which may precede changes (increase) in serum creatinine concentration. The use of functional imaging together with standard monitoring of the graft status increases the efficiency of pathology detection and promotes early clinical response. The combination of renoscintigraphy parameters, GFR, CRP, and ESR can be one of the non-invasive markers for diagnosing RT pathology, which improves the risk assessment of late graft rejection.
- Open Access
- 12 June 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (3) , 50-56
Features of the dynamics of immune system parameters in the application of combined organ and cell transplantation of the kidney
Objective. To compare the immunological parameters of recipients after kidney transplantation who received different variants of immunosuppressive therapy. Materials and methods. The 1st study group included 15 patients who underwent the first combined organ and cell transplantation of a kidney from a living related donor. The 2nd study group included 30 recipients who underwent the first kidney transplantation from a living related donor and received standard immunosuppressive therapy. The main diagnosis in all study recipients was endstage renal disease due to progression of chronic glomerulonephritis, prolonged by programmatic hemodialysis. The immune status of the recipients was assessed by the results of immunophenotyping of peripheral blood lymphocytes involved in transplantation immunity and by the levels of circulating class G immunoglobulins. The control group consisted of 30 healthy blood donors. Results. There was a more pronounced decrease in the levels of T and NKlymphocytes in peripheral blood in patients of group 1 than in patients of group 2, a compensatory higher level of Blymphocytes in patients of both study groups in the first 30 days after kidney transplantation and statistically significant (p < 0.05) higher levels of regulatory T cells from day 14 to day 360 of the observation period in patients of group 1 in contrast to patients of group 2. Patients in group 1 also had statistically significantly (p < 0.05) higher levels of circulating immunoglobulins of class G at all times during the observation period. Conclusions. Additional administration of stem cells increases the pool of regulatory T cells, restores the levels of B cells and circulating immunoglobulins of class G, and plays a role in the longterm stabilization of immunoglobulin fraction proteins and provides better results of kidney transplantation.
- 12 June 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (3) , 50-56
Open AccessFeatures of the dynamics of immune system parameters in the application of combined organ and cell transplantation of the kidney
Objective. To compare the immunological parameters of recipients after kidney transplantation who received different variants of immunosuppressive therapy. Materials and methods. The 1st study group included 15 patients who underwent the first combined organ and cell transplantation of a kidney from a living related donor. The 2nd study group included 30 recipients who underwent the first kidney transplantation from a living related donor and received standard immunosuppressive therapy. The main diagnosis in all study recipients was endstage renal disease due to progression of chronic glomerulonephritis, prolonged by programmatic hemodialysis. The immune status of the recipients was assessed by the results of immunophenotyping of peripheral blood lymphocytes involved in transplantation immunity and by the levels of circulating class G immunoglobulins. The control group consisted of 30 healthy blood donors. Results. There was a more pronounced decrease in the levels of T and NKlymphocytes in peripheral blood in patients of group 1 than in patients of group 2, a compensatory higher level of Blymphocytes in patients of both study groups in the first 30 days after kidney transplantation and statistically significant (p < 0.05) higher levels of regulatory T cells from day 14 to day 360 of the observation period in patients of group 1 in contrast to patients of group 2. Patients in group 1 also had statistically significantly (p < 0.05) higher levels of circulating immunoglobulins of class G at all times during the observation period. Conclusions. Additional administration of stem cells increases the pool of regulatory T cells, restores the levels of B cells and circulating immunoglobulins of class G, and plays a role in the longterm stabilization of immunoglobulin fraction proteins and provides better results of kidney transplantation.
- Open Access
- 11 April 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (2) , 37-41
Choice of surgical technique for nephrectomy in a living related donor
Objective. To compare the results of open and laparoscopic nephrectomy in a living related donor. Materials and methods. The study included 20 patients who underwent laparoscopic (group I, n=10) and open (group II, n=10) left-sided donor nephrectomy. Results. The comparative analysis showed the advantages of laparoscopic donor nephrectomy over open donor nephrectomy, which consisted of a shorter duration of the operation - (141 ± 19.9) and (167 ± 22.7) min, respectively, a lower incidence of surgical complications, fewer bed days - 5.5± 1.95 and 6.3± 1.94, respectively, lower intensity and duration of postoperative pain. At the same time, the duration of renal thermal ischemia was statistically significantly shorter in open surgery (18.6± 4.7) s than in laparoscopic surgery (135± 43) s, but without any difference in the short-term function of the renal transplant in the recipient. Conclusions. In the case of laparoscopic donor nephrectomy, the negative consequences of the operation for a living donor are reduced, but the experience of the transplant surgeon is decisive when choosing a method of donor nephrectomy.
- 11 April 2025
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (2) , 37-41
Open AccessChoice of surgical technique for nephrectomy in a living related donor
Objective. To compare the results of open and laparoscopic nephrectomy in a living related donor. Materials and methods. The study included 20 patients who underwent laparoscopic (group I, n=10) and open (group II, n=10) left-sided donor nephrectomy. Results. The comparative analysis showed the advantages of laparoscopic donor nephrectomy over open donor nephrectomy, which consisted of a shorter duration of the operation - (141 ± 19.9) and (167 ± 22.7) min, respectively, a lower incidence of surgical complications, fewer bed days - 5.5± 1.95 and 6.3± 1.94, respectively, lower intensity and duration of postoperative pain. At the same time, the duration of renal thermal ischemia was statistically significantly shorter in open surgery (18.6± 4.7) s than in laparoscopic surgery (135± 43) s, but without any difference in the short-term function of the renal transplant in the recipient. Conclusions. In the case of laparoscopic donor nephrectomy, the negative consequences of the operation for a living donor are reduced, but the experience of the transplant surgeon is decisive when choosing a method of donor nephrectomy.
- Open Access
- 28 March 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(86),p. 79-87
The particularities of T-lymphocytes levels after the induction immunosuppressive therapy with stem cells in kidney transplant recipients
Induction immunosuppressive therapy is used to prevent early kidney transplant rejection and has a positive effect on the kidney transplantation long-term results, but the chronic rejection remains the main cause of transplanted organs function failure in the late post-transplantation period. Previous studies showe positive effects of stem cells therapy in kidney transplantation - lower ischemic-reperfusion injury and improvement of the organs and tissues functional state. Аim - to assess the dynamics of Т-lymphocytes after kidney transplantation with stem cells complex induction immunosuppressive therapy . Materials and methods. The study group included 15 adult kidney transplant recipients who underwent first kidney allotransplantation from a living related donor with intravenous administration of (2-3)×106/kg of body weight human umbilical cord blood stem cells in 2020-2023 along with standard immunosuppressive therapy. The comparison group consisted of 30 corresponding recipients who received standard immunosuppressive therapy. The immune status of the recipients was assessed based on the results of immunophenotyping of peripheral blood lymphocytes, which are involved in the work of transplantation immunity. Results. In the study group we saw more pronounced decrease in the level of CD45+ lymphocytes, CD3+19- T-lymphocytes compared to the comparison group. During the first month after transplantation we saw significant decrease of the I-reg level in both groups, after which the indicators approached to the control group, but did not reach it. In the study group, significantly higher rates of T-reg cell recovery were observed from the 14th day of observation. Conclusions. The introduction of cord blood stem cells to recipients before kidney transplantation inhibits alloactivation of the immune system to donor antigens and contributes to the creation of a protolerogenic environment in the recipient's body, which allows to predict the long-term kidney transplant function of in the future. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of all institutions mentioned in the work. Informed consent of the patients was obtained for the research. The authors declare no conflict of interest.
- 28 March 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(86),p. 79-87
Open AccessThe particularities of T-lymphocytes levels after the induction immunosuppressive therapy with stem cells in kidney transplant recipients
Induction immunosuppressive therapy is used to prevent early kidney transplant rejection and has a positive effect on the kidney transplantation long-term results, but the chronic rejection remains the main cause of transplanted organs function failure in the late post-transplantation period. Previous studies showe positive effects of stem cells therapy in kidney transplantation - lower ischemic-reperfusion injury and improvement of the organs and tissues functional state. Аim - to assess the dynamics of Т-lymphocytes after kidney transplantation with stem cells complex induction immunosuppressive therapy . Materials and methods. The study group included 15 adult kidney transplant recipients who underwent first kidney allotransplantation from a living related donor with intravenous administration of (2-3)×106/kg of body weight human umbilical cord blood stem cells in 2020-2023 along with standard immunosuppressive therapy. The comparison group consisted of 30 corresponding recipients who received standard immunosuppressive therapy. The immune status of the recipients was assessed based on the results of immunophenotyping of peripheral blood lymphocytes, which are involved in the work of transplantation immunity. Results. In the study group we saw more pronounced decrease in the level of CD45+ lymphocytes, CD3+19- T-lymphocytes compared to the comparison group. During the first month after transplantation we saw significant decrease of the I-reg level in both groups, after which the indicators approached to the control group, but did not reach it. In the study group, significantly higher rates of T-reg cell recovery were observed from the 14th day of observation. Conclusions. The introduction of cord blood stem cells to recipients before kidney transplantation inhibits alloactivation of the immune system to donor antigens and contributes to the creation of a protolerogenic environment in the recipient's body, which allows to predict the long-term kidney transplant function of in the future. The research was carried out in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of all institutions mentioned in the work. Informed consent of the patients was obtained for the research. The authors declare no conflict of interest.
- Open Access
- 14 March 2024
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 13 (1) , 55-59
New approaches to kidney transplantation in Ukraine
The number of patients with end-stage renal disease in Ukraine, as in the whole world, increases. Kidney transplantation remains the most effective method of treatment for such patients. After 1933, when in Ukraine the world’s first kidney transplantation was performed, the number of there surgeries remained insignificant (up to 130 operations per year). In 2018–2020, the reform of transplantation in Ukraine began due to the change of some laws. And as a result, the number of such operations is growing every year. Control over the transplantation process is carried out by a newly created body of the Ministry of Health of Ukraine, the Ukrainian Transplant Coordination Center. New transplant centers are being created, immunological support of transplant couples is being improved using polymerase chain reaction, flow cytometers and solid-phase methods due to HLA typing of the donor and recipient according to A, B, C, DR, DQ, DP loci, detection of anti-HLA antibodies, allele-specific anti-HLA antibodies using single antigen bead assay. Examinations of patients are carried out at the pre-transplantation stage and as part of monitoring after transplantation. Given the military actions, the lack of aviation and the long time of getting to the clinic, it became possible to preserve organs by methods of hypothermic or nomothermic perfusion. The number of organ transplantations is increasing. In 2023, several successful simultaneous heart and kidney, kidney and pancreas transplantations were performed. The problems of overcoming tissue incompatibility, choosing the optimal immunosuppressive therapy regimen for a given patient, training of nephrologists, wider and more effective use of perfusion machines, new protocols of immunosuppressive therapy, studying the peculiarities of kidney transplantation from marginal donors (the number of which in Ukraine prevails), kidney transplantation in highly sensitized recipients are still actual in Ukraine. The cooperation with our European and American colleagues is very important to improve the long-term results of such operations.
- 14 March 2024
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 13 (1) , 55-59
Open AccessNew approaches to kidney transplantation in Ukraine
The number of patients with end-stage renal disease in Ukraine, as in the whole world, increases. Kidney transplantation remains the most effective method of treatment for such patients. After 1933, when in Ukraine the world’s first kidney transplantation was performed, the number of there surgeries remained insignificant (up to 130 operations per year). In 2018–2020, the reform of transplantation in Ukraine began due to the change of some laws. And as a result, the number of such operations is growing every year. Control over the transplantation process is carried out by a newly created body of the Ministry of Health of Ukraine, the Ukrainian Transplant Coordination Center. New transplant centers are being created, immunological support of transplant couples is being improved using polymerase chain reaction, flow cytometers and solid-phase methods due to HLA typing of the donor and recipient according to A, B, C, DR, DQ, DP loci, detection of anti-HLA antibodies, allele-specific anti-HLA antibodies using single antigen bead assay. Examinations of patients are carried out at the pre-transplantation stage and as part of monitoring after transplantation. Given the military actions, the lack of aviation and the long time of getting to the clinic, it became possible to preserve organs by methods of hypothermic or nomothermic perfusion. The number of organ transplantations is increasing. In 2023, several successful simultaneous heart and kidney, kidney and pancreas transplantations were performed. The problems of overcoming tissue incompatibility, choosing the optimal immunosuppressive therapy regimen for a given patient, training of nephrologists, wider and more effective use of perfusion machines, new protocols of immunosuppressive therapy, studying the peculiarities of kidney transplantation from marginal donors (the number of which in Ukraine prevails), kidney transplantation in highly sensitized recipients are still actual in Ukraine. The cooperation with our European and American colleagues is very important to improve the long-term results of such operations.
- Open Access
- 30 December 2022
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 89 (11-12) , 46-52
Peculiarities of the induction immunosuppressive therapy in renal transplantation
Peculiarities of the induction immunosuppressive therapy in renal transplantation
- 30 December 2022
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 89 (11-12) , 46-52
Open AccessPeculiarities of the induction immunosuppressive therapy in renal transplantation
Peculiarities of the induction immunosuppressive therapy in renal transplantation
- Open Access
- 29 December 2021
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 10 (4) , 229-236
The opportunity of stem cells application in kidney transplantation: clinical studies (review)
Kidney transplantation remains the optimal method of end-stage renal disease treatment, but the result of such operations depends on the immune response of the recipient to the transplanted organ. Side effects of modern immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and increased risk of cancer, negatively affect the long-term results of transplantation. In recent years, studies of the properties and uses of stem cells have aroused considerable interest and expectations. The biological characteristics of stem cells, including multi-row differentiation, self-guidance, paracrine effects, immunomodulation, ability to suppress the immune response against graft, have opened new horizons for their use in kidney transplantation, but according to different studies, the safety and effectiveness of stem cells clinical use remain controversial. The use of stem cells in animal models with renal failure shows better results in the postoperative period and provides an opportunity for clinical research in the context of creating alternative induction therapy in kidney transplantation. The preclinical efficiency of stem cells in the chronic renal failure model and renal allotransplantation in laboratory animals showed their unique potential to improve function and repair the damaged kidney. They also demonstrate immunosuppressive effects that realize in the inhibition of T-cell proliferation and dendritic cells maturation, the induction of Т-regulatory cells, which can improve the long-term results of kidney allotransplantation. This review summarizes the results of previous studies and is aimed to provide an objective point of view based on a comprehensive analysis of currently known advantages and disadvantages of stem cell therapy in kidney transplantation and highlights aspects that require further research.
- 29 December 2021
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 10 (4) , 229-236
Open AccessThe opportunity of stem cells application in kidney transplantation: clinical studies (review)
Kidney transplantation remains the optimal method of end-stage renal disease treatment, but the result of such operations depends on the immune response of the recipient to the transplanted organ. Side effects of modern immunosuppressive drugs, such as nephrotoxicity, opportunistic infection, and increased risk of cancer, negatively affect the long-term results of transplantation. In recent years, studies of the properties and uses of stem cells have aroused considerable interest and expectations. The biological characteristics of stem cells, including multi-row differentiation, self-guidance, paracrine effects, immunomodulation, ability to suppress the immune response against graft, have opened new horizons for their use in kidney transplantation, but according to different studies, the safety and effectiveness of stem cells clinical use remain controversial. The use of stem cells in animal models with renal failure shows better results in the postoperative period and provides an opportunity for clinical research in the context of creating alternative induction therapy in kidney transplantation. The preclinical efficiency of stem cells in the chronic renal failure model and renal allotransplantation in laboratory animals showed their unique potential to improve function and repair the damaged kidney. They also demonstrate immunosuppressive effects that realize in the inhibition of T-cell proliferation and dendritic cells maturation, the induction of Т-regulatory cells, which can improve the long-term results of kidney allotransplantation. This review summarizes the results of previous studies and is aimed to provide an objective point of view based on a comprehensive analysis of currently known advantages and disadvantages of stem cell therapy in kidney transplantation and highlights aspects that require further research.
- Open Access
- 25 December 2020
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 9 (4) , 240-248
Возможность использования стволовых клеток при трансплантации почки: экспериментальные исследования (обзор литературы)
Долгосрочные результаты выживания почечных трансплантатов остаются неудовлетворительными. Наиболее распространенной причиной потери трансплантата является хроническая дисфункция трансплантированной почки, которая побуждает нас к активному исследованию новых возможных схем иммуносупрессивной терапии. Проведенные исследования использования стволовых клеток на животных моделях с почечной недостаточностью показывают лучшие результаты в послеоперационном периоде и дают старт для клинических исследований в контексте создания альтернативной индукционной терапии при трансплантации почки. При проведении литературного анализа доклинической эффективности применения мезенхимальных стволовых клеток при хронической почечной недостаточности и аллотрансплантации почки у лабораторных животных обнаружили их уникальный потенциал для улучшения функции и восстановления поврежденной почки, а также наличие иммуносупрессивных эффектов, которые включают угнетение пролиферации Т-клеток и созревания дендритных клеток и индукцию Т-регуляторных клеток. Они могут улучшить отдаленные результаты аллотрансплантации почки, однако это требует дальнейших исследований.
- 25 December 2020
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 9 (4) , 240-248
Open AccessВозможность использования стволовых клеток при трансплантации почки: экспериментальные исследования (обзор литературы)
Долгосрочные результаты выживания почечных трансплантатов остаются неудовлетворительными. Наиболее распространенной причиной потери трансплантата является хроническая дисфункция трансплантированной почки, которая побуждает нас к активному исследованию новых возможных схем иммуносупрессивной терапии. Проведенные исследования использования стволовых клеток на животных моделях с почечной недостаточностью показывают лучшие результаты в послеоперационном периоде и дают старт для клинических исследований в контексте создания альтернативной индукционной терапии при трансплантации почки. При проведении литературного анализа доклинической эффективности применения мезенхимальных стволовых клеток при хронической почечной недостаточности и аллотрансплантации почки у лабораторных животных обнаружили их уникальный потенциал для улучшения функции и восстановления поврежденной почки, а также наличие иммуносупрессивных эффектов, которые включают угнетение пролиферации Т-клеток и созревания дендритных клеток и индукцию Т-регуляторных клеток. Они могут улучшить отдаленные результаты аллотрансплантации почки, однако это требует дальнейших исследований.
- Open Access
- 16 December 2019
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 8 (4) , 210-216
Особенности реакции иммунной системы у реципиентов почечного трансплантата детского возраста
Актуальность. Для улучшения результатов трансплантации почки необходимо учитывать возрастную категорию пациента и состояние его иммунной системы. Цель работы: изучить особенности реакции иммунной системы на почечный трансплантат у реципиентов детского возраста. Материалы и методы. Проведен ретроспективный анализ цитометрического исследования субпопуляций лимфоцитов периферической крови, гейтованных по СD45++ со следующими антигенами: CD3/4/8/45 (T-хелперы, T-цитотоксические), CD3/DR/19/45 (T-активированные, B-клетки), CD 3/16/56/45 (T-NK- и NK-лимфоциты), CD38/45/19 (активированные, общие и B-лимфоциты), расчетного иммунорегуляторного индекса (Ireg) — CD4+/CD8+ и уровней общих иммуноглобулинов (Ig) классов A, M, G в сыворотке крови в динамике у 38 взрослых реципиентов и 16 детей, которым в 2016–2019 гг. в Национальном институте хирургии и трансплантологии им. А.А. Шалимова НАМН Украины была выполнена первая аллотрансплантация почки от живого родственного донора. Исследование состояния иммунной системы проводили перед трансплантацией почки, в конце 1-го и 6-го месяцев после трансплантации. Результаты. У детей наблюдаются более выраженные признаки реакции иммунной системы на трансплантат и иммуносупрессивную терапию, чем у взрослых. Часть лимфоцитов, участвующих в ответе иммунной системы, у детей демонстрирует значительно большее подавление в конце первого месяца наблюдения (относительное количество лимфоцитов CD45++, относительное и абсолютное количество T-лимфоцитов CD3+19–, активированных лимфоцитов CD38+45+high и В-активированных лимфоцитов CD38+19+) и через шесть месяцев (абсолютное количество лимфоцитов CD45++, абсолютное и относительное количество В-лимфоцитов CD3–19+ Т-активированных CD3+DR+). Другие субпопуляции лимфоцитов, наоборот, показывают значительно больший рост через 30 дней (абсолютное и относительное количество В-лимфоцитов CD3–19+) и через шесть месяцев после операции (относительное количество лимфоцитов CD45++ и T-лимфоцитов CD3+19–, относительное и абсолютное количество активированных лимфоцитов CD38+45+high). Некоторые из субпопуляций лимфоцитов у детей быстрее восстанавливаются до предоперационного уровня (относительное количество лимфоцитов CD45++ и Т-хелперов CD4+8–). Выводы. Анализ полученных данных свидетельствует о том, что реакция иммунной системы на почечный трансплантат у детей и взрослых проявляется разнонаправленными изменениями абсолютного и относительного количества субпопуляций лимфоцитов и уровней иммуноглобулинов, что необходимо учесть при выборе схем иммуносупрессивной терапии.
- 16 December 2019
- Published by ARC Publication Services LLC in KIDNEYS
- Vol. 8 (4) , 210-216
Open AccessОсобенности реакции иммунной системы у реципиентов почечного трансплантата детского возраста
Актуальность. Для улучшения результатов трансплантации почки необходимо учитывать возрастную категорию пациента и состояние его иммунной системы. Цель работы: изучить особенности реакции иммунной системы на почечный трансплантат у реципиентов детского возраста. Материалы и методы. Проведен ретроспективный анализ цитометрического исследования субпопуляций лимфоцитов периферической крови, гейтованных по СD45++ со следующими антигенами: CD3/4/8/45 (T-хелперы, T-цитотоксические), CD3/DR/19/45 (T-активированные, B-клетки), CD 3/16/56/45 (T-NK- и NK-лимфоциты), CD38/45/19 (активированные, общие и B-лимфоциты), расчетного иммунорегуляторного индекса (Ireg) — CD4+/CD8+ и уровней общих иммуноглобулинов (Ig) классов A, M, G в сыворотке крови в динамике у 38 взрослых реципиентов и 16 детей, которым в 2016–2019 гг. в Национальном институте хирургии и трансплантологии им. А.А. Шалимова НАМН Украины была выполнена первая аллотрансплантация почки от живого родственного донора. Исследование состояния иммунной системы проводили перед трансплантацией почки, в конце 1-го и 6-го месяцев после трансплантации. Результаты. У детей наблюдаются более выраженные признаки реакции иммунной системы на трансплантат и иммуносупрессивную терапию, чем у взрослых. Часть лимфоцитов, участвующих в ответе иммунной системы, у детей демонстрирует значительно большее подавление в конце первого месяца наблюдения (относительное количество лимфоцитов CD45++, относительное и абсолютное количество T-лимфоцитов CD3+19–, активированных лимфоцитов CD38+45+high и В-активированных лимфоцитов CD38+19+) и через шесть месяцев (абсолютное количество лимфоцитов CD45++, абсолютное и относительное количество В-лимфоцитов CD3–19+ Т-активированных CD3+DR+). Другие субпопуляции лимфоцитов, наоборот, показывают значительно больший рост через 30 дней (абсолютное и относительное количество В-лимфоцитов CD3–19+) и через шесть месяцев после операции (относительное количество лимфоцитов CD45++ и T-лимфоцитов CD3+19–, относительное и абсолютное количество активированных лимфоцитов CD38+45+high). Некоторые из субпопуляций лимфоцитов у детей быстрее восстанавливаются до предоперационного уровня (относительное количество лимфоцитов CD45++ и Т-хелперов CD4+8–). Выводы. Анализ полученных данных свидетельствует о том, что реакция иммунной системы на почечный трансплантат у детей и взрослых проявляется разнонаправленными изменениями абсолютного и относительного количества субпопуляций лимфоцитов и уровней иммуноглобулинов, что необходимо учесть при выборе схем иммуносупрессивной терапии.